Health ICER MIDWEST CEPAC WORKS TO KEEP UP WITH WELL-INFORMED NASH PATIENT ADVOCATES Jason Junior May 2, 2023 <!-- Name:DistributionId Value:8829412 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True --> <!-- Name:IcbCode Value: -->…
Health PATIENT GROUPS DECLARE ICER REVIEW OF NASH MEDICATIONS CAUSES MORE UNCERTAINTY AND CONTROVERSIES… Jason Junior Apr 28, 2023 <!-- Name:DistributionId Value:8828197 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…
Health More Positive Imcivree Data; ICER Reviews Tirzepatide; SGLT2 Inhibitors for Syncope? Jason Junior Feb 20, 2022 Interim data from a long-term extension study of setmelanotide (Imcivree) for pediatric and adult patients with Bardet-Biedl Syndrome found an…
Health New Jardiance Indication? Bariatric Surgery for NASH; ICER Reviews Tirzepatide Jason Junior Nov 14, 2021 The FDA accepted a supplemental new drug application for empagliflozin (Jardiance) as a treatment for heart failure independent of left…
Health Walmart’s Cheap Insulin; Obesity Jaw Lock Backlash; ICER to Review Tirzepatide Jason Junior Jul 4, 2021 Walmart announced plans to sell a cheaper version of analog insulin -- ReliOn NovoLog -- at a price tag of about $73 for a vial or $86 for a…